Skip to main navigation Skip to search Skip to main content

Chronic Granulomatous Disease, The Mcleod Phenotype and the Contiguous Gene Deletion Syndrome - a Review

  • Casey E. Watkins
  • , John Litchfield
  • , Eunkyung Song
  • , Gayatri B. Jaishankar
  • , Niva Misra
  • , Nikhil Holla
  • , Michelle Duffourc
  • , Guha Krishnaswamy
  • , Gayatri Jaishankar
  • East Tennessee State University

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic Granulomatous Disease (CGD), a disorder of the NADPH oxidase system, results in phagocyte functional defects and subsequent infections with bacterial and fungal pathogens (such as Aspergillus species and Candida albicans). Deletions and missense, frameshift, or nonsense mutations in the gp91 phox gene (also termed CYBB), located in the Xp21.1 region of the X chromosome, are associated with the most common form of CGD. When larger X-chromosomal deletions occur, including the XK gene deletion, a so-called "Contiguous Gene Deletion Syndrome" may result. The contiguous gene deletion syndrome is known to associate the Kell phenotype/McLeod syndrome with diseases such as X-linked chronic granulomatous disease, Duchenne muscular dystrophy, and X-linked retinitis pigmentosa. These patients are often complicated and management requires special attention to the various facets of the syndrome. © 2011 Watkins et al; licensee BioMed Central Ltd.

Original languageAmerican English
JournalClinical and Molecular Allergy
Volume9
DOIs
StatePublished - Nov 23 2011

Keywords

  • anemia
  • chronic
  • gene deletion
  • granulomatous disease
  • hemolytic
  • human
  • kx antigen
  • xk kell blood group precursor (mcleod phenotype)

Cite this